Atlas Trials

Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis

Clinical trial NCT05363449 · COMPLETED

Trial details

NCT number
NCT05363449
Sponsor
Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tinea CrurisTinea Pedis
Start date
2022-02-17
Primary completion
2023-11-14
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.